NYSE:USPH - U.S. Physical Therapy Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$94.40 +0.65 (+0.69 %)
(As of 05/24/2018 04:00 PM ET)
Previous Close$93.75
Today's Range$93.60 - $94.95
52-Week Range$56.50 - $95.20
Volume41,800 shs
Average Volume53,431 shs
Market Capitalization$1.19 billion
P/E Ratio45.24
Dividend Yield0.98%
Beta1.09

About U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy logoU.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNYSE:USPH
CUSIP90337L10
Phone713-297-7000

Debt

Debt-to-Equity Ratio0.21
Current Ratio1.67
Quick Ratio1.67

Price-To-Earnings

Trailing P/E Ratio45.24
Forward P/E Ratio38.53
P/E Growth3.39

Sales & Book Value

Annual Sales$414.05 million
Price / Sales2.89
Cash Flow$2.8824 per share
Price / Cash32.75
Book Value$16.45 per share
Price / Book5.74

Profitability

EPS (Most Recent Fiscal Year)$2.08
Net Income$22.25 million
Net Margins4.90%
Return on Equity13.20%
Return on Assets6.43%

Miscellaneous

Employees4,300
Outstanding Shares12,670,000

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Thursday, May 3rd. Shareholders of record on Friday, May 11th will be given a dividend of $0.23 per share on Friday, June 8th. This represents a $0.92 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend is Thursday, May 10th. View U.S. Physical Therapy's Dividend History.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) issued its quarterly earnings data on Thursday, May, 3rd. The company reported $0.56 EPS for the quarter, hitting analysts' consensus estimates of $0.56. The company had revenue of $108.34 million for the quarter, compared to analysts' expectations of $107.18 million. U.S. Physical Therapy had a return on equity of 13.20% and a net margin of 4.90%. View U.S. Physical Therapy's Earnings History.

What price target have analysts set for USPH?

4 analysts have issued twelve-month target prices for U.S. Physical Therapy's shares. Their predictions range from $68.00 to $90.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $77.00 in the next twelve months. View Analyst Ratings for U.S. Physical Therapy.

What are Wall Street analysts saying about U.S. Physical Therapy stock?

Here are some recent quotes from research analysts about U.S. Physical Therapy stock:
  • 1. Cantor Fitzgerald analysts commented, "1Q18 results were in-line with our expectations, driven by a 7.4% jump in patient visits, new practices and a full quarter’s contribution from its workforce performance solutions business." (5/3/2018)
  • 2. Barrington Research analysts commented, "We are maintaining our MARKET PERFORM investment rating on USPH shares. While we really like this business and think its leadership is among the best we have seen in healthcare services, the stock’s current valuation is higher than we can ever recall in our 14 years of covering this idea. We would certainly reconsider our investment rating if shares were to weaken a bit." (3/9/2018)
  • 3. According to Zacks Investment Research, "U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. " (3/9/2018)

Who are some of U.S. Physical Therapy's key competitors?

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the folowing people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 54)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 63)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 61)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 54)
  • Mr. Jon C. Bates, VP & Corp. Controller

Has U.S. Physical Therapy been receiving favorable news coverage?

News coverage about USPH stock has been trending somewhat positive on Thursday, Accern reports. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. U.S. Physical Therapy earned a coverage optimism score of 0.08 on Accern's scale. They also assigned media coverage about the company an impact score of 44.94 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (13.07%), Neuberger Berman Group LLC (7.57%), Kayne Anderson Rudnick Investment Management LLC (4.62%), Dimensional Fund Advisors LP (3.90%), Northern Trust Corp (1.57%) and Copeland Capital Management LLC (1.38%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Lawrance W Mcafee and Mark J Brookner. View Institutional Ownership Trends for U.S. Physical Therapy.

Which institutional investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, JPMorgan Chase & Co., CT Mason, Royal Bank of Canada, Spark Investment Management LLC, Citadel Advisors LLC, Tiverton Asset Management LLC and Wedge Capital Management L L P NC. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.

Which institutional investors are buying U.S. Physical Therapy stock?

USPH stock was acquired by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Carillon Tower Advisers Inc., Russell Investments Group Ltd., BlackRock Inc., Thomson Horstmann & Bryant Inc., Great Lakes Advisors LLC, Coldstream Capital Management Inc. and WINTON GROUP Ltd. View Insider Buying and Selling for U.S. Physical Therapy.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $94.40.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.19 billion and generates $414.05 million in revenue each year. The company earns $22.25 million in net income (profit) each year or $2.08 on an earnings per share basis. U.S. Physical Therapy employs 4,300 workers across the globe.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]


MarketBeat Community Rating for U.S. Physical Therapy (USPH)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  150 (Vote Outperform)
Underperform Votes:  237 (Vote Underperform)
Total Votes:  387
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe USPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

U.S. Physical Therapy (NYSE:USPH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for U.S. Physical Therapy in the last 12 months. Their average twelve-month price target is $77.00, suggesting that the stock has a possible downside of 18.43%. The high price target for USPH is $90.00 and the low price target for USPH is $68.00. There are currently 4 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.002.502.502.50
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $77.00$77.00$74.50$70.25
Price Target Upside: 18.43% downside11.03% downside5.34% downside2.50% downside

U.S. Physical Therapy (NYSE:USPH) Consensus Price Target History

Price Target History for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE:USPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/4/2018Cantor FitzgeraldDowngradeOverweight ➝ NeutralLowView Rating Details
4/25/2018SidotiDowngradeBuy ➝ NeutralHighView Rating Details
3/9/2018Barrington ResearchReiterated RatingHoldHighView Rating Details
2/23/2018Jefferies GroupSet Price TargetHold$76.00LowView Rating Details
11/7/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
(Data available from 5/24/2016 forward)

Earnings

U.S. Physical Therapy (NYSE:USPH) Earnings History and Estimates Chart

Earnings by Quarter for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE:USPH) Earnings Estimates

Current Year EPS Consensus Estimate: $2.45 EPS
Next Year EPS Consensus Estimate: $2.64 EPS

U.S. Physical Therapy (NYSE USPH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2018Q1 2018$0.56$0.56$107.18 million$108.34 millionViewN/AView Earnings Details
3/8/2018Q4 2017$0.49$0.49$104.12 million$109.20 millionViewN/AView Earnings Details
11/2/2017Q3 2017$0.5180$0.48$102.69 million$103.03 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.6030$0.59$102.93 million$104.25 millionViewListenView Earnings Details
6/29/2017Q1 2017$0.49$0.51$97.60 million$97.57 millionViewN/AView Earnings Details
6/7/2017Q4 2016$0.49$90.86 millionViewN/AView Earnings Details
11/3/2016Q316$0.49$0.46$33.94 million$88.30 millionViewN/AView Earnings Details
8/4/2016Q216$0.55$0.57$90.01 million$90.40 millionViewN/AView Earnings Details
5/5/2016Q116$0.39$0.43$83.35 million$86.90 millionViewN/AView Earnings Details
3/3/2016Q4$0.47$0.48$85.47 million$86.72 millionViewN/AView Earnings Details
11/5/2015Q315$0.48$0.47$84.07 million$84.00 millionViewN/AView Earnings Details
8/6/2015Q215$0.58$0.51$84.24 million$83.30 millionViewN/AView Earnings Details
5/7/2015Q115$0.35$0.34$74.74 million$77.24 millionViewN/AView Earnings Details
3/5/2015$0.39$0.41$75.29 million$79.39 millionViewN/AView Earnings Details
11/6/2014Q314$0.42$0.43$75.50 million$77.70 millionViewN/AView Earnings Details
8/7/2014Q214$0.44$0.52$74.25 million$66.90 millionViewN/AView Earnings Details
5/8/2014Q114$0.30$0.35$67.70 million$62.80 millionViewN/AView Earnings Details
3/6/2014Q413$0.35$0.32$65.33 million$62.38 millionViewN/AView Earnings Details
11/7/2013Q313$0.40$0.38$66.32 million$65.83 millionViewN/AView Earnings Details
8/8/2013Q2 2013$0.42$0.41$66.49 million$67.22 millionViewN/AView Earnings Details
5/9/2013Q1 2013$0.33$0.31$62.26 million$63.10 millionViewN/AView Earnings Details
3/7/2013Q4 2012$0.33$0.34$61.99 million$62.70 millionViewN/AView Earnings Details
11/8/2012Q312$0.38$0.38$63.77 million$62.80 millionViewN/AView Earnings Details
8/9/2012$0.44$0.41ViewN/AView Earnings Details
5/3/2012$0.34$0.38ViewN/AView Earnings Details
3/8/2012$0.28$0.29ViewN/AView Earnings Details
11/3/2011$0.35$0.34ViewN/AView Earnings Details
8/4/2011$0.41$0.41ViewN/AView Earnings Details
5/5/2011$0.27$0.31ViewN/AView Earnings Details
3/3/2011$0.25$0.28ViewN/AView Earnings Details
11/4/2010Q3 2010$0.31$0.33ViewN/AView Earnings Details
8/5/2010Q2 2010$0.36$0.38ViewN/AView Earnings Details
5/6/2010Q1 2010$0.23$0.25ViewN/AView Earnings Details
3/4/2010Q4 2009$0.20$0.19ViewN/AView Earnings Details
11/5/2009Q3 2009$0.23$0.26ViewN/AView Earnings Details
8/6/2009Q2 2009$0.24$0.31ViewN/AView Earnings Details
5/7/2009Q1 2009$0.20$0.23ViewN/AView Earnings Details
3/5/2009Q4 2008$0.21$0.19ViewN/AView Earnings Details
11/6/2008Q3 2008$0.22$0.21ViewN/AView Earnings Details
8/7/2008Q2 2008$0.23$0.24ViewN/AView Earnings Details
5/8/2008Q1 2008$0.20$0.20ViewN/AView Earnings Details
3/6/2008Q4 2007$0.19$0.21ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

U.S. Physical Therapy (NYSE:USPH) Dividend Information

U.S. Physical Therapy pays an annual dividend of $0.92 per share, with a dividend yield of 0.97%. USPH's next quarterly dividend payment will be made on Friday, June 8. The company has grown its dividend for the last 7 consecutive years and is increasing its dividend by an average of 18.60% each year. U.S. Physical Therapy pays out 44.23% of its earnings out as a dividend.
Next Dividend:6/8/2018
Annual Dividend:$0.92
Dividend Yield:0.97%
Dividend Growth:18.60% (3 Year Average)
Payout Ratio(s):44.23% (Trailing 12 Months of Earnings)
37.55% (Based on This Year's Estimates)
34.85% (Based on Next Year's Estimates)
31.92% (Based on Cash Flow)
Track Record:7 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE:USPH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/3/2018Quarterly$0.231.02%5/10/20185/11/20186/8/2018
3/9/2018quarterly$0.231.06%3/20/20183/21/20184/13/2018
10/31/2017Quarterly$0.201.21%11/16/201711/17/201712/8/2017
8/3/2017quarterly$0.201.27%8/17/20178/21/20179/8/2017
5/31/2017Quarterly$0.201.25%6/14/20176/16/20177/7/2017
4/3/2017quarterly$0.201.25%4/12/20174/17/20175/5/2017
11/3/2016quarterly$0.171.28%11/16/201611/18/201612/2/2016
8/4/2016quarterly$0.171.12%8/17/20168/19/20169/2/2016
5/5/2016quarterly$0.171.31%5/13/20165/17/20166/3/2016
3/4/2016quarterly$0.171.33%3/16/20163/18/20164/1/2016
11/6/2015quarterly$0.151.15%11/13/201511/17/201512/4/2015
8/7/2015quarterly$0.151.18%8/14/20158/18/20159/4/2015
5/7/2015quarterly$0.151.24%5/14/20155/18/20156/5/2015
3/6/2015quarterly$0.151.33%3/18/20153/20/20154/3/2015
11/6/2014quarterly$0.121.23%11/13/201411/17/201412/5/2014
8/7/2014quarterly$0.121.32%8/14/20148/18/20149/5/2014
5/8/2014quarterly$0.121.54%5/16/20145/20/20146/6/2014
3/7/2014quarterly$0.121.48%3/17/20143/19/20144/4/2014
11/7/2013quarterly$0.101.36%11/13/201311/15/201312/6/2013
8/8/2013quarterly$0.101.28%8/16/20138/20/20139/6/2013
5/9/2013quarterly$0.101.59%5/15/20135/17/20136/7/2013
3/7/2013quarterly$0.101.71%3/13/20133/15/20133/29/2013
(Data available from 1/1/2013 forward)

Insider Trades

U.S. Physical Therapy (NYSE USPH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 95.80%
Insider Trading History for U.S. Physical Therapy (NYSE:USPH)
Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE USPH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2018Mark J BrooknerDirectorSell1,250$91.83$114,787.50View SEC Filing  
5/11/2018Christopher J. ReadingCEOSell2,672$92.16$246,251.52View SEC Filing  
5/11/2018Edward L KuntzDirectorSell2,000$92.02$184,040.003,750View SEC Filing  
5/9/2018Christopher J. ReadingCEOSell13,639$92.01$1,254,924.39View SEC Filing  
3/15/2018Glenn McdowellCOOSell2,900$82.55$239,395.00View SEC Filing  
3/13/2018Glenn McdowellCOOSell2,743$86.11$236,199.73View SEC Filing  
3/12/2018Bernard A Harris JrDirectorSell6,000$86.53$519,180.00View SEC Filing  
3/12/2018Lawrance W McafeeCFOSell2,000$86.06$172,120.00View SEC Filing  
3/9/2018Lawrance W. McafeeCFOSell5,000$83.35$416,750.00View SEC Filing  
12/27/2017Mark J. BrooknerDirectorSell2,625$71.23$186,978.75View SEC Filing  
12/12/2017Clayton TrierDirectorSell4,250$71.97$305,872.50View SEC Filing  
12/12/2017Lawrance W. McafeeCFOSell2,000$72.56$145,120.00View SEC Filing  
11/16/2017Lawrance W. McafeeCFOSell2,000$68.68$137,360.00View SEC Filing  
11/8/2017Christopher J. ReadingCEOSell15,000$66.52$997,800.00View SEC Filing  
11/8/2017Lawrance W. McafeeCFOSell5,200$66.37$345,124.00View SEC Filing  
11/3/2017Lawrance W. McafeeCFOSell800$69.21$55,368.00View SEC Filing  
8/30/2017Glenn McdowellCOOSell2,598$57.00$148,086.00View SEC Filing  
8/29/2017Glenn McdowellCOOSell1,004$57.01$57,238.04View SEC Filing  
8/22/2017Glenn McdowellCOOSell1,664$59.91$99,690.24View SEC Filing  
8/11/2017Lawrance W. McafeeCFOSell3,000$62.04$186,120.00View SEC Filing  
8/10/2017Bernard A Harris JrDirectorSell5,000$62.00$310,000.0026,422View SEC Filing  
12/9/2016Edward L. KuntzDirectorSell2,500$68.40$171,000.00View SEC Filing  
11/22/2016Lawrance W. McafeeCFOSell2,000$62.55$125,100.00View SEC Filing  
11/15/2016Glenn McdowellCOOSell4,047$61.15$247,474.05View SEC Filing  
11/10/2016Lawrance W. McafeeCFOSell2,000$58.04$116,080.00View SEC Filing  
9/19/2016Christopher J. ReadingCEOSell8,000$64.01$512,080.00View SEC Filing  
9/19/2016Lawrance W. McafeeCFOSell2,000$64.00$128,000.00View SEC Filing  
8/25/2016Lawrance W. McafeeCFOSell2,000$62.50$125,000.00View SEC Filing  
8/9/2016Glenn McdowellCOOSell4,047$60.20$243,629.40View SEC Filing  
8/5/2016Lawrance W. McafeeCFOSell2,000$59.60$119,200.00View SEC Filing  
6/10/2016Lawrance W McafeeCFOSell2,000$59.27$118,540.0039,212View SEC Filing  
5/20/2016Regg E SwansonDirectorSell3,000$57.29$171,870.00View SEC Filing  
5/11/2016Bernard A Harris JrDirectorSell3,000$58.10$174,300.0031,834View SEC Filing  
5/9/2016Glenn McdowellCOOSell8,354$57.95$484,114.3034,417View SEC Filing  
5/9/2016Lawrance W McafeeCFOSell4,000$54.90$219,600.0043,212View SEC Filing  
3/14/2016Jerald L PullinsDirectorSell5,000$51.35$256,750.0024,596View SEC Filing  
3/4/2016Lawrance W McafeeCFOSell5,000$52.74$263,700.0045,212View SEC Filing  
12/29/2015Clayton TrierDirectorSell4,500$55.23$248,535.0011,250View SEC Filing  
12/16/2015Lawrance W McafeeCFOSell4,000$51.24$204,960.0038,852View SEC Filing  
11/20/2015Christopher J. ReadingCEOSell25,000$52.12$1,303,000.0094,157View SEC Filing  
11/11/2015Glenn McdowellCOOSell4,299$51.25$220,323.7531,411View SEC Filing  
11/6/2015Lawrance W McafeeCFOSell4,000$51.00$204,000.0042,852View SEC Filing  
8/25/2015Lawrance W McafeeCFOSell2,000$47.06$94,120.0046,852View SEC Filing  
8/24/2015Harry S ChapmanDirectorBuy1,000$46.90$46,900.0033,750View SEC Filing  
8/18/2015Regg E SwansonDirectorSell2,000$51.68$103,360.00View SEC Filing  
3/20/2015Lawrance W McafeeCFOSell2,350$48.25$113,387.50View SEC Filing  
3/19/2015Christopher J ReadingCEOSell22,600$48.12$1,087,512.00View SEC Filing  
3/17/2015Glenn McdowellCOOSell2,299$47.92$110,168.08View SEC Filing  
3/16/2015Christopher J ReadingCEOSell2,400$49.29$118,296.00View SEC Filing  
3/16/2015Glenn McdowellCOOSell2,000$49.13$98,260.00View SEC Filing  
3/16/2015Lawrance W McafeeCFOSell2,650$49.07$130,035.50View SEC Filing  
3/9/2015Clayton TrierDirectorSell3,250$45.05$146,412.50View SEC Filing  
3/6/2015Lawrance W McafeeCFOSell10,000$45.34$453,400.00View SEC Filing  
12/5/2014Glenn McdowellCOOSell19,621$39.95$783,858.95View SEC Filing  
12/2/2014Clayton TrierDirectorSell3,250$39.49$128,342.50View SEC Filing  
11/28/2014Christopher J ReadingCEOSell9,759$39.29$383,431.11View SEC Filing  
11/25/2014Christopher J ReadingCEOSell10,241$39.00$399,399.00View SEC Filing  
11/11/2014Clayton TrierDirectorSell1,002$39.83$39,909.66View SEC Filing  
11/7/2014Lawrance W McafeeCFOSell10,000$39.23$392,300.00View SEC Filing  
9/5/2014Mark J BrooknerDirectorSell3,105$35.80$111,159.00View SEC Filing  
9/3/2014Mark J BrooknerDirectorSell549$35.82$19,665.18View SEC Filing  
9/2/2014Jerald L PullinsDirectorSell3,000$35.46$106,380.00View SEC Filing  
8/29/2014Mark J BrooknerDirectorSell96$35.75$3,432.00View SEC Filing  
8/27/2014Jerald L PullinsDirectorSell3,000$35.86$107,580.00View SEC Filing  
8/8/2014Lawrance W McafeeCFOSell5,000$34.55$172,750.00View SEC Filing  
3/28/2014Jerald PullinsDirectorSell6,000$32.92$197,520.0035,846View SEC Filing  
3/12/2014Jerald PullinsDirectorSell7,000$32.98$230,860.0041,846View SEC Filing  
3/7/2014Lawrance McafeeCFOSell10,000$32.07$320,700.0060,852View SEC Filing  
11/22/2013Lawrance McafeeCFOSell5,000$33.02$165,100.0055,852View SEC Filing  
11/11/2013Harry ChapmanDirectorBuy1,750$30.18$52,815.0026,750View SEC Filing  
11/8/2013Lawrance McafeeCFOSell5,000$29.71$148,550.0060,852View SEC Filing  
9/4/2013Glenn McdowellCOOSell11,148$28.54$318,163.9233,228View SEC Filing  
8/9/2013Lawrance McafeeCFOSell10,000$29.81$298,100.0065,852View SEC Filing  
6/13/2013Christopher J ReadingCEOSell20,000$29.05$581,000.00View SEC Filing  
6/10/2013Lawrance W McafeeCFOSell5,000$29.18$145,900.00View SEC Filing  
5/28/2013Clayton TrierDirectorSell6,500$28.35$184,275.00View SEC Filing  
5/10/2013Lawrance W McafeeCFOSell5,000$24.55$122,750.00View SEC Filing  
12/12/2012Harry S ChapmanDirectorBuy1,200$27.02$32,424.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

U.S. Physical Therapy (NYSE USPH) News Headlines

Source:
DateHeadline
FY2018 Earnings Forecast for U.S. Physical Therapy, Inc. Issued By Cantor Fitzgerald (USPH)FY2018 Earnings Forecast for U.S. Physical Therapy, Inc. Issued By Cantor Fitzgerald (USPH)
www.americanbankingnews.com - May 24 at 8:32 AM
Cantor Fitzgerald Weighs in on U.S. Physical Therapy, Inc.s FY2019 Earnings (USPH)Cantor Fitzgerald Weighs in on U.S. Physical Therapy, Inc.'s FY2019 Earnings (USPH)
www.americanbankingnews.com - May 23 at 7:37 AM
Zacks: Brokerages Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Quarterly Sales of $113.32 MillionZacks: Brokerages Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Quarterly Sales of $113.32 Million
www.americanbankingnews.com - May 23 at 4:14 AM
Zacks: Brokerages Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Earnings of $0.70 Per ShareZacks: Brokerages Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Earnings of $0.70 Per Share
www.americanbankingnews.com - May 21 at 7:44 AM
U.S. Physical Therapy, Inc. (USPH) Receives Consensus Rating of "Hold" from AnalystsU.S. Physical Therapy, Inc. (USPH) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - May 20 at 1:37 AM
U.S. Physical Therapy, Inc. (USPH) Director Mark J. Brookner Sells 1,250 SharesU.S. Physical Therapy, Inc. (USPH) Director Mark J. Brookner Sells 1,250 Shares
www.americanbankingnews.com - May 17 at 8:34 PM
U.S. Physical Therapy to Present at the Bank of America Merrill Lynch 2018 Health Care ConferenceU.S. Physical Therapy to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
finance.yahoo.com - May 16 at 4:10 PM
Insider Selling: U.S. Physical Therapy, Inc. (USPH) Director Sells 2,000 Shares of StockInsider Selling: U.S. Physical Therapy, Inc. (USPH) Director Sells 2,000 Shares of Stock
www.americanbankingnews.com - May 14 at 1:25 PM
U.S. Physical Therapy, Inc. (USPH) CEO Christopher J. Reading Sells 2,672 SharesU.S. Physical Therapy, Inc. (USPH) CEO Christopher J. Reading Sells 2,672 Shares
www.americanbankingnews.com - May 11 at 4:41 PM
Insider Selling: U.S. Physical Therapy, Inc. (USPH) CEO Sells 13,639 Shares of StockInsider Selling: U.S. Physical Therapy, Inc. (USPH) CEO Sells 13,639 Shares of Stock
www.americanbankingnews.com - May 11 at 4:21 PM
Ex-Dividend Reminder: Hilton Worldwide Holdings, American Water Works and U.S. Physical TherapyEx-Dividend Reminder: Hilton Worldwide Holdings, American Water Works and U.S. Physical Therapy
www.nasdaq.com - May 8 at 4:09 PM
Brokers Set Expectations for U.S. Physical Therapy, Inc.s FY2019 Earnings (USPH)Brokers Set Expectations for U.S. Physical Therapy, Inc.'s FY2019 Earnings (USPH)
www.americanbankingnews.com - May 7 at 5:00 AM
U.S. Physical Therapy, Inc. (USPH) CEO Chris Reading on Q1 2018 Results - Earnings Call TranscriptU.S. Physical Therapy, Inc. (USPH) CEO Chris Reading on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 5 at 4:08 PM
U.S. Physical Therapy, Inc. (USPH) Expected to Announce Quarterly Sales of $111.97 MillionU.S. Physical Therapy, Inc. (USPH) Expected to Announce Quarterly Sales of $111.97 Million
www.americanbankingnews.com - May 5 at 2:17 AM
U.S. Physical Therapy (USPH) Issues Quarterly  Earnings Results, Hits ExpectationsU.S. Physical Therapy (USPH) Issues Quarterly Earnings Results, Hits Expectations
www.americanbankingnews.com - May 4 at 8:55 PM
U.S. Physical Therapy (USPH) Cut to "Neutral" at Cantor FitzgeraldU.S. Physical Therapy (USPH) Cut to "Neutral" at Cantor Fitzgerald
www.americanbankingnews.com - May 4 at 3:17 PM
U.S. Physical Therapy, Inc. (USPH) Declares Dividend of $0.23U.S. Physical Therapy, Inc. (USPH) Declares Dividend of $0.23
www.americanbankingnews.com - May 4 at 9:56 AM
Edited Transcript of USPH earnings conference call or presentation 3-May-18 2:30pm GMTEdited Transcript of USPH earnings conference call or presentation 3-May-18 2:30pm GMT
finance.yahoo.com - May 4 at 9:41 AM
U.S. Physical Therapys (USPH) Buy Rating Reaffirmed at Cantor FitzgeraldU.S. Physical Therapy's (USPH) Buy Rating Reaffirmed at Cantor Fitzgerald
www.americanbankingnews.com - May 3 at 11:15 PM
 Brokerages Anticipate U.S. Physical Therapy, Inc. (USPH) to Announce $0.55 Earnings Per Share Brokerages Anticipate U.S. Physical Therapy, Inc. (USPH) to Announce $0.55 Earnings Per Share
www.americanbankingnews.com - May 3 at 9:25 PM
U.S. Physical Therapy EPS in-line, beats on revenueU.S. Physical Therapy EPS in-line, beats on revenue
seekingalpha.com - May 3 at 9:40 AM
U.S. Physical Therapy Reports First Quarter 2018 ResultsU.S. Physical Therapy Reports First Quarter 2018 Results
finance.yahoo.com - May 3 at 9:40 AM
U.S. Physical Therapy: 1Q Earnings SnapshotU.S. Physical Therapy: 1Q Earnings Snapshot
finance.yahoo.com - May 3 at 9:40 AM
US Physical Therapy (USPH) Acquires Majority Interest in Industrial Injury Prevention CompanyUS Physical Therapy (USPH) Acquires Majority Interest in Industrial Injury Prevention Company
www.streetinsider.com - May 1 at 4:08 PM
U.S. Physical Therapy Makes Second Acquisition in Industrial Injury Prevention SectorU.S. Physical Therapy Makes Second Acquisition in Industrial Injury Prevention Sector
finance.yahoo.com - May 1 at 9:48 AM
Reviewing U.S. Physical Therapy (USPH) & DCC (DCCPF)Reviewing U.S. Physical Therapy (USPH) & DCC (DCCPF)
www.americanbankingnews.com - April 27 at 10:33 AM
Sidoti Downgrades U.S. Physical Therapy (USPH) to NeutralSidoti Downgrades U.S. Physical Therapy (USPH) to Neutral
www.streetinsider.com - April 27 at 10:25 AM
Analyzing DCC (DCCPF) and U.S. Physical Therapy (USPH)Analyzing DCC (DCCPF) and U.S. Physical Therapy (USPH)
www.americanbankingnews.com - April 26 at 3:30 PM
U.S. Physical Therapy (USPH) to Release Earnings on ThursdayU.S. Physical Therapy (USPH) to Release Earnings on Thursday
www.americanbankingnews.com - April 26 at 3:28 AM
U.S. Physical Therapy (USPH) Lowered to Neutral at SidotiU.S. Physical Therapy (USPH) Lowered to Neutral at Sidoti
www.americanbankingnews.com - April 25 at 11:42 AM
U.S. Physical Therapy, Inc. (USPH) Given Consensus Recommendation of "Hold" by AnalystsU.S. Physical Therapy, Inc. (USPH) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 25 at 1:36 AM
Financial Survey: DCC (DCCPF) versus U.S. Physical Therapy (USPH)Financial Survey: DCC (DCCPF) versus U.S. Physical Therapy (USPH)
www.americanbankingnews.com - April 24 at 5:30 PM
U.S. Physical Therapy (USPH) vs. DCC (DCCPF) Financial ReviewU.S. Physical Therapy (USPH) vs. DCC (DCCPF) Financial Review
www.americanbankingnews.com - April 24 at 10:00 AM
Critical Survey: U.S. Physical Therapy (USPH) & DCC (DCCPF)Critical Survey: U.S. Physical Therapy (USPH) & DCC (DCCPF)
www.americanbankingnews.com - April 23 at 11:04 AM
DCC (DCCPF) vs. U.S. Physical Therapy (USPH) Head-To-Head ReviewDCC (DCCPF) vs. U.S. Physical Therapy (USPH) Head-To-Head Review
www.americanbankingnews.com - April 23 at 3:34 AM
U.S. Physical Therapy (USPH) versus DCC (DCCPF) Critical ContrastU.S. Physical Therapy (USPH) versus DCC (DCCPF) Critical Contrast
www.americanbankingnews.com - April 20 at 9:27 AM
Head-To-Head Comparison: U.S. Physical Therapy (USPH) and DCC (DCCPF)Head-To-Head Comparison: U.S. Physical Therapy (USPH) and DCC (DCCPF)
www.americanbankingnews.com - April 19 at 10:40 AM
U.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $107.18 MillionU.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $107.18 Million
www.americanbankingnews.com - April 18 at 2:28 AM
Zacks: Analysts Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Earnings of $0.55 Per ShareZacks: Analysts Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Earnings of $0.55 Per Share
www.americanbankingnews.com - April 16 at 5:14 PM
U.S. Physical Therapy, Inc. Schedules First Quarter 2018 Release and Conference Call for Thursday, May 3, 2018U.S. Physical Therapy, Inc. Schedules First Quarter 2018 Release and Conference Call for Thursday, May 3, 2018
finance.yahoo.com - April 12 at 4:09 PM
Critical Comparison: DCC (DCCPF) and U.S. Physical Therapy (USPH)Critical Comparison: DCC (DCCPF) and U.S. Physical Therapy (USPH)
www.americanbankingnews.com - April 12 at 9:11 AM
Financial Survey: U.S. Physical Therapy (USPH) and DCC (DCCPF)Financial Survey: U.S. Physical Therapy (USPH) and DCC (DCCPF)
www.americanbankingnews.com - April 10 at 8:19 AM
Reviewing DCC (DCCPF) and U.S. Physical Therapy (USPH)Reviewing DCC (DCCPF) and U.S. Physical Therapy (USPH)
www.americanbankingnews.com - April 9 at 1:27 AM
U.S. Physical Therapy (USPH) Stock Rating Upgraded by BidaskClubU.S. Physical Therapy (USPH) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - April 5 at 6:21 PM
U.S. Physical Therapy (USPH) Upgraded to "Buy" at ValuEngineU.S. Physical Therapy (USPH) Upgraded to "Buy" at ValuEngine
www.americanbankingnews.com - April 2 at 10:52 PM
Zacks: Analysts Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Quarterly Sales of $107.18 MillionZacks: Analysts Anticipate U.S. Physical Therapy, Inc. (USPH) Will Announce Quarterly Sales of $107.18 Million
www.americanbankingnews.com - April 1 at 2:16 AM
U.S. Physical Therapy, Inc. (USPH) Receives Average Recommendation of "Hold" from AnalystsU.S. Physical Therapy, Inc. (USPH) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 31 at 1:36 AM
$0.55 Earnings Per Share Expected for U.S. Physical Therapy, Inc. (USPH) This Quarter$0.55 Earnings Per Share Expected for U.S. Physical Therapy, Inc. (USPH) This Quarter
www.americanbankingnews.com - March 30 at 9:16 PM
Cantor Fitzgerald Reiterates Buy Rating for U.S. Physical Therapy (USPH)Cantor Fitzgerald Reiterates Buy Rating for U.S. Physical Therapy (USPH)
www.americanbankingnews.com - March 29 at 9:04 PM
What Investors Should Know About US. Physical Therapy Inc.’s (NYSE:USPH) Financial StrengthWhat Investors Should Know About US. Physical Therapy Inc.’s (NYSE:USPH) Financial Strength
finance.yahoo.com - March 16 at 10:12 AM

SEC Filings

U.S. Physical Therapy (NYSE:USPH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

U.S. Physical Therapy (NYSE:USPH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

U.S. Physical Therapy (NYSE USPH) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.